Ohnishi et al. [48] demonstrated that the neuroprotective effect of GA on intracerebral hemorrhage-related pathogenic events was not mediated by glucocorticoid receptors or modulation of nitric oxide production and was reversed by exogenous HMGB1 application. The gene discussed is NR3C1; the disease is intracerebral hemorrhage.